These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28024980)

  • 1. Validation of novel cost-effective antimicrobial gradient strips for the determination of carbapenem susceptibility in Enterobacteriaceae.
    Sekar R; Srivani S; Lallitha S; Thenmozhi P; Devisri T; Amudhan M; Mythreyee M
    J Glob Antimicrob Resist; 2017 Mar; 8():97-101. PubMed ID: 28024980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B Etest
    Kulengowski B; Ribes JA; Burgess DS
    Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Jönsson A; Jacobsson S; Foerster S; Cole MJ; Unemo M
    APMIS; 2018 Oct; 126(10):822-827. PubMed ID: 30191618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
    García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae.
    Maalej SM; Meziou MR; Rhimi FM; Hammami A
    Lett Appl Microbiol; 2011 Nov; 53(5):546-51. PubMed ID: 21895730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
    Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
    J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.
    Steward CD; Mohammed JM; Swenson JM; Stocker SA; Williams PP; Gaynes RP; McGowan JE; Tenover FC
    J Clin Microbiol; 2003 Jan; 41(1):351-8. PubMed ID: 12517872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques.
    Mal PB; Jabeen K; Farooqi J; Unemo M; Khan E
    BMC Microbiol; 2016 Oct; 16(1):236. PubMed ID: 27724873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Clinical Evaluation of Etest Meropenem-Vaborbactam (bioMérieux) for Susceptibility Testing of
    Jean S; Garrett S; Anglade C; Bridon L; Davies L; Garner OB; Richards J; Wallace M; Wootton M; Burnham CA
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31619532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.
    Kaase M; Szabados F; Anders A; Gatermann SG
    J Clin Microbiol; 2014 Jun; 52(6):1893-7. PubMed ID: 24648559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
    Lee M; Chung HS
    J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019
    Humphries RM; Hindler JA; Shaffer K; Campeau SA
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of
    Blanchard LS; Armstrong TP; Kresken M; Emery CL; Ying YX; Sauvonnet V; Zambardi G
    J Clin Microbiol; 2023 Mar; 61(3):e0165022. PubMed ID: 36877080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    Cantón R; Canut A; Morosini MI; Oliver A
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of M.I.C.E. and Etest with CLSI agar dilution for antimicrobial susceptibility testing against oxacillin-resistant Staphylococcus spp.
    Campana EH; Carvalhaes CG; Nonato B; Machado AM; Gales AC
    PLoS One; 2014; 9(4):e94627. PubMed ID: 24732297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
    Matuschek E; Åhman J; Webster C; Kahlmeter G
    Clin Microbiol Infect; 2018 Aug; 24(8):865-870. PubMed ID: 29221995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints.
    Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM
    J Clin Microbiol; 2015 Mar; 53(3):816-23. PubMed ID: 25540403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of tigecycline susceptibility testing methods for Acinetobacter baumannii and Enterobacteriaceae.
    Zhang J; Zhao C; Chen H; Wang X; Li H; Zhang Y; Wang H
    J Glob Antimicrob Resist; 2015 Jun; 3(2):75-79. PubMed ID: 27873673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.